🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
601,32 USD
Máx. histórico
601,32
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
430,02 – 609,99
Variación hoy
+0,87%
Cierre anterior
596,13
Rango de hoy
596,14 – 606,16
Volumen hoy
595.233
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,54 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 1 día
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 26/01/2004 | 11,40 | 11,75 | 11,15 | 11,70 | -3,55% | 5,26% | 4.392.200 |
| 23/01/2004 | 11,90 | 12,59 | 11,83 | 12,13 | +2,02% | 6,34% | 1.243.400 |
| 22/01/2004 | 11,40 | 12,17 | 11,40 | 11,89 | +4,48% | 6,75% | 1.602.000 |
| 21/01/2004 | 11,32 | 11,40 | 11,17 | 11,38 | -0,22% | 2,03% | 663.600 |
| 20/01/2004 | 11,42 | 11,50 | 11,31 | 11,40 | +0,00% | 1,66% | 1.680.200 |
| 16/01/2004 | 11,43 | 11,64 | 11,39 | 11,40 | -1,30% | 2,14% | 721.000 |
| 15/01/2004 | 11,56 | 11,64 | 11,38 | 11,55 | -0,35% | 2,21% | 429.800 |
| 14/01/2004 | 11,76 | 11,98 | 11,40 | 11,59 | -0,64% | 4,89% | 540.800 |
| 13/01/2004 | 11,72 | 11,72 | 11,38 | 11,67 | -0,26% | 2,90% | 558.400 |
| 12/01/2004 | 11,57 | 11,70 | 11,48 | 11,70 | +1,30% | 1,90% | 350.200 |
| 09/01/2004 | 11,50 | 11,79 | 11,47 | 11,55 | +0,39% | 2,83% | 743.200 |
| 08/01/2004 | 11,59 | 11,63 | 11,43 | 11,50 | -0,99% | 1,73% | 1.260.600 |
| 07/01/2004 | 11,50 | 11,68 | 11,41 | 11,62 | +1,66% | 2,30% | 1.462.200 |
| 06/01/2004 | 11,69 | 11,70 | 11,43 | 11,43 | -2,39% | 2,31% | 1.276.600 |
| 05/01/2004 | 11,75 | 11,93 | 11,66 | 11,71 | -0,30% | 2,26% | 376.800 |
| 02/01/2004 | 11,75 | 11,97 | 11,67 | 11,74 | +2,31% | 2,51% | 264.800 |
| 31/12/2003 | 11,74 | 11,79 | 11,48 | 11,48 | -1,84% | 2,64% | 542.600 |
| 30/12/2003 | 11,71 | 11,86 | 11,57 | 11,69 | -0,47% | 2,52% | 181.000 |
| 29/12/2003 | 11,51 | 12,00 | 11,51 | 11,75 | +1,16% | 4,30% | 297.200 |
| 26/12/2003 | 11,50 | 11,75 | 11,50 | 11,61 | +0,96% | 2,22% | 182.200 |
| 24/12/2003 | 11,50 | 11,65 | 11,50 | 11,50 | -1,33% | 1,26% | 151.800 |
| 23/12/2003 | 11,52 | 11,70 | 11,40 | 11,66 | +1,00% | 2,60% | 375.000 |
| 22/12/2003 | 11,48 | 11,69 | 11,41 | 11,54 | -0,52% | 2,40% | 309.000 |
| 19/12/2003 | 11,47 | 11,75 | 11,18 | 11,60 | +2,65% | 4,97% | 1.199.000 |
| 18/12/2003 | 10,77 | 11,70 | 10,77 | 11,30 | +4,82% | 8,64% | 2.802.000 |
| 17/12/2003 | 10,40 | 10,86 | 10,34 | 10,78 | +3,65% | 5,00% | 1.440.000 |
| 16/12/2003 | 10,14 | 10,47 | 10,08 | 10,40 | +1,41% | 3,80% | 712.800 |
| 15/12/2003 | 10,60 | 10,75 | 10,13 | 10,26 | -3,03% | 5,85% | 425.800 |
| 12/12/2003 | 10,49 | 10,58 | 10,34 | 10,58 | +1,00% | 2,24% | 303.800 |
| 11/12/2003 | 10,12 | 10,72 | 10,12 | 10,47 | +2,20% | 5,98% | 750.600 |